Showing results (81-90 of 465) with videos related to
Sort By:
Pageof 47
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 22, 2009
Continuous dopaminergic stimulation achieved by duodenal levodopa infusionPer Odin, Erik Wolters, Angelo AntoniniJournal of Neural Transmission (Vienna, Austria : 1996)|September 6, 2023
Current and novel infusion therapies for patients with Parkinson's diseaseAngelo Antonini, Valentina D'Onofrio, Andrea GuerraFrontiers in Neurology|November 27, 2020
Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on ParkinsonismBeatrice Roiter, Giorgio Pigato, Angelo AntoniniExpert Review of Neurotherapeutics|January 13, 2015
Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesiasPantelis Stathis, Spiridon Konitsiotis, Angelo AntoniniFrontiers in Aging Neuroscience|March 20, 2026
Financial abilities in patients with Parkinson's disease and mild cognitive impairment: unveiling cognitive and neurofunctional correlates of basic and advanced financial skillsLaura Danesin, Giulia Pagnin, Lorenza Maistrello, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 5, 2020
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International StudyAndrea Quattrone, Angelo Antonini, David E Vaillancourt, et al.Annals of Clinical and Translational Neurology|December 21, 2024
Alpha-synuclein RT-QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patientsAron Emmi, Angela Mammana, Michele Sandre, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2026
Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive FunctionEleonora Fiorenzato, Simone Cauzzo, Giulia Musso, et al.Frontiers in Neurology|September 2, 2025
Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217Giulia Musso, Eleonora Fiorenzato, Valentina Misenti, et al.Nature Reviews. Neurology|November 4, 2024
Parkinson disease therapy: current strategies and future research prioritiesFabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.Pageof 47